Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupinder Brar

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Substance Abuse Treatment, Prevention, and Policy|November 13, 2019
Fentanyl assisted treatment: a possible role in the opioid overdose epidemic?Geoff Bardwell, Evan Wood, Rupinder Brar
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
Matias Raski, Christy Sutherland, Rupinder Brar
Journal of Addiction Medicine|March 7, 2020
Case Study: Naltrexone for the Treatment of Nitrous Oxide UseSarah Ickowicz, Rupinder Brar, Seonaid Nolan
BMJ Case Reports|August 3, 2019
Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorderRupinder Brar, Christy Sutherland, Seonaid Nolan
Drug and Alcohol Review|December 10, 2019
Initiation of injectable opioid agonist treatment in hospital: A case reportMatthew McAdam, Rupinder Brar, Samantha Young
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
From methadone to Methadose: Lessons learned from methadone formulation change in British ColumbiaMatias Raski, Christy Sutherland, Rupinder Brar
Journal of Addiction Medicine|February 12, 2022
Supporting Self-isolation for COVID-19 With "Risk Mitigation" Prescribing and Housing Supports for People Who Use Drugs: A Case ReportRan Ha Hong, Rupinder Brar, Nadia Fairbairn
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 22, 2020
Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug marketPrivia A Randhawa, Rupinder Brar, Seonaid Nolan
Drug and Alcohol Review|July 14, 2020
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case seriesRupinder Brar, Nadia Fairbairn, Christy Sutherland, et al.
Journal of Addiction Medicine|February 4, 2020
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case SeriesValerie Giang, Rupinder Brar, Christy Sutherland, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Substance Abuse Treatment, Prevention, and Policy|November 13, 2019
Fentanyl assisted treatment: a possible role in the opioid overdose epidemic?Geoff Bardwell, Evan Wood, Rupinder Brar
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
Matias Raski, Christy Sutherland, Rupinder Brar
Journal of Addiction Medicine|March 7, 2020
Case Study: Naltrexone for the Treatment of Nitrous Oxide UseSarah Ickowicz, Rupinder Brar, Seonaid Nolan
BMJ Case Reports|August 3, 2019
Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorderRupinder Brar, Christy Sutherland, Seonaid Nolan
Drug and Alcohol Review|December 10, 2019
Initiation of injectable opioid agonist treatment in hospital: A case reportMatthew McAdam, Rupinder Brar, Samantha Young
Canadian Family Physician Medecin De Famille Canadien|November 19, 2020
From methadone to Methadose: Lessons learned from methadone formulation change in British ColumbiaMatias Raski, Christy Sutherland, Rupinder Brar
Journal of Addiction Medicine|February 12, 2022
Supporting Self-isolation for COVID-19 With "Risk Mitigation" Prescribing and Housing Supports for People Who Use Drugs: A Case ReportRan Ha Hong, Rupinder Brar, Nadia Fairbairn
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 22, 2020
Buprenorphine-naloxone "microdosing": an alternative induction approach for the treatment of opioid use disorder in the wake of North America's increasingly potent illicit drug marketPrivia A Randhawa, Rupinder Brar, Seonaid Nolan
Drug and Alcohol Review|July 14, 2020
Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine/naloxone micro-dosing - a case seriesRupinder Brar, Nadia Fairbairn, Christy Sutherland, et al.
Journal of Addiction Medicine|February 4, 2020
HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case SeriesValerie Giang, Rupinder Brar, Christy Sutherland, et al.
Pageof 4